Cite
Assessing the significance of chromosomal aberrations in cancer: Methodology and application to glioma
MLA
David Linhart, et al. “Assessing the Significance of Chromosomal Aberrations in Cancer: Methodology and Application to Glioma.” Proceedings of the National Academy of Sciences, vol. 104, Dec. 2007, pp. 20007–12. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....c04ecdee57e8d12e50e737dbe395ead4&authtype=sso&custid=ns315887.
APA
David Linhart, William R. Sellers, Levi A. Garraway, Gad Getz, Jordi Barretina, Julie H. Huang, Roman K. Thomas, Kinjal Shah, Ralph M. Debiasi, Matthew Meyerson, John R. Prensner, Leia Nghiemphu, Paul S. Mischel, Teli Hsueh, Mark A. Rubin, Francesca Demichelis, Todd Golub, Eric S. Lander, Ingo K. Mellinghoff, … Timothy F. Cloughesy. (2007). Assessing the significance of chromosomal aberrations in cancer: Methodology and application to glioma. Proceedings of the National Academy of Sciences, 104, 20007–20012.
Chicago
David Linhart, William R. Sellers, Levi A. Garraway, Gad Getz, Jordi Barretina, Julie H. Huang, Roman K. Thomas, et al. 2007. “Assessing the Significance of Chromosomal Aberrations in Cancer: Methodology and Application to Glioma.” Proceedings of the National Academy of Sciences 104 (December): 20007–12. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....c04ecdee57e8d12e50e737dbe395ead4&authtype=sso&custid=ns315887.